Hormone-dependent beta-casein mRNA stabilization requires ongoing protein synthesis.

Area of Science:

• Molecular Endocrinology
• Cell Biology
• Gene Expression Regulation

Background:

• Hormonal regulation of gene expression involves complex posttranscriptional mechanisms.
• Mammary epithelial cells (COMMA D) are a model for studying casein gene expression.
• The role of protein synthesis in hormone-mediated gene regulation requires elucidation.

Purpose of the Study:

• To investigate the necessity of ongoing protein synthesis for hormone-induced beta-casein gene expression.
• To determine the effect of protein synthesis inhibition on existing beta-casein mRNA levels.
• To understand the role of accumulated labile proteins in mediating hormone effects on casein mRNA stability.

Main Methods:

• Utilized protein synthesis inhibitors (cycloheximide, anisomycin) in COMMA D cells.
• Administered lactogenic hormones (insulin, PRL, glucocorticoids) to cell cultures.
• Measured beta-casein mRNA accumulation and decay rates using quantitative techniques.
• Compared mRNA stability under various hormonal and inhibitor treatment conditions.

Main Results:

• Protein synthesis inhibitors prevented glucocorticoid-induced beta-casein mRNA increase and caused rapid mRNA decay (half-life ~2h).
• Beta-actin and histone H4 mRNA levels increased under inhibitor treatment.
• Prolonged pretreatment (48h) with all three lactogenic hormones diminished inhibitor effects on beta-casein mRNA.
• Beta-casein mRNA exhibited long half-life after hormone withdrawal in the absence of inhibitors.

Conclusions:

• Ongoing protein synthesis is essential for the stabilization of cytoplasmic beta-casein mRNA.
• Hormone treatment leads to the accumulation of a labile protein that selectively stabilizes casein mRNA.
• This highlights a critical posttranscriptional regulatory pathway in mammary gland function.